概述

  • 产品名称Anti-RPL7A抗体
    参阅全部 RPL7A 一抗
  • 描述
    兔多克隆抗体to RPL7A
  • 经测试应用适用于: IP, IHC-P, WBmore details
  • 种属反应性
    与反应: Mouse, Human
    预测可用于: Rat, Rabbit, Horse, Chicken, Guinea pig, Cow, Turkey, Pig, Xenopus laevis, Chimpanzee, Zebrafish, Rhesus monkey, Gorilla, Orangutan, Xenopus tropicalis
  • 免疫原

    Synthetic peptide corresponding to a region between residue 215 and the C-terminus (residue 266) of human RPL7A (NP_000963.1).

  • 阳性对照
    • Whole cell lysate from HeLa, MCF7 or 293T cells.

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • 存储溶液Preservative: 0.09% Sodium Azide
    Constituents: 0.1% BSA, Tris buffered saline
  • Concentration information loading...
  • 纯度Immunogen affinity purified
  • 克隆多克隆
  • 同种型IgG
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab70753 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IP Use at 2-5 µg/mg of lysate.
IHC-P 1/100 - 1/500. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
WB 1/2000 - 1/10000. Detects a band of approximately 35 kDa (predicted molecular weight: 30 kDa).

靶标

Anti-RPL7A antibody 图像

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon carcinoma (left) and mouse renal cell carcinoma (right) tissues labelling RPL7A with ab70753 at 1/200 (1µg/ml). Detection: DAB.
  • All lanes : Anti-RPL7A antibody (ab70753) at 0.1 µg/ml

    Lane 1 : HeLa whole cell lysate at 20 µg
    Lane 2 : HeLa whole cell lysate at 4 µg
    Lane 3 : MCF7 whole cell lysate at 20 µg
    Lane 4 : 293T whole cell lysate at 20 µg

    Developed using the ECL technique

    Predicted band size : 30 kDa
    Observed band size : 35 kDa (why is the actual band size different from the predicted?)


    Exposure time : 5 seconds

Anti-RPL7A antibody (ab70753)参考文献

This product has been referenced in:
  • Yang PY  et al. Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities. J Am Chem Soc 132:656-66 (2010). Read more (PubMed: 20028024) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab70753.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"